z-logo
open-access-imgOpen Access
Adjonction du daratumumab à l’association bortézomib, lénalidomide et dexaméthasone dans le myélome multiple éligible à une autogreffe de cellules souches hématopoïétiques
Author(s) -
Nicolas Stocker
Publication year - 2020
Publication title -
hématologie
Language(s) - French
Resource type - Journals
eISSN - 1766-0327
pISSN - 1264-7527
DOI - 10.1684/hma.2020.1599
Subject(s) - medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom